Zura Bio Limited Stock Current Valuation
| ZURA Stock | 1.76 0.03 1.73% |
Valuation analysis of Zura Bio Limited helps investors to measure Zura Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to -0.79. The current year's Enterprise Value Multiple is expected to grow to -0.79. Fundamental drivers impacting Zura Bio's valuation include:
Undervalued
Today
Please note that Zura Bio's price fluctuation is unstable at this time. Calculation of the real value of Zura Bio Limited is based on 3 months time horizon. Increasing Zura Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zura Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zura Stock. However, Zura Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.76 | Real 5.05 | Target 15.0 | Hype 1.61 | Naive 1.9 |
The real value of Zura Stock, also known as its intrinsic value, is the underlying worth of Zura Bio Limited Company, which is reflected in its stock price. It is based on Zura Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zura Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Zura Bio Limited helps investors to forecast how Zura stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zura Bio more accurately as focusing exclusively on Zura Bio's fundamentals will not take into account other important factors: Zura Bio Limited Company Current Valuation Analysis
Zura Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Zura Bio Current Valuation | 105.46 M |
Most of Zura Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zura Bio Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Zura Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Zura Bio is extremely important. It helps to project a fair market value of Zura Stock properly, considering its historical fundamentals such as Current Valuation. Since Zura Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zura Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zura Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Zura Bio Limited has a Current Valuation of 105.46 M. This is 99.27% lower than that of the Biotechnology sector and 97.73% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.37% higher than that of the company.
Zura Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zura Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zura Bio could also be used in its relative valuation, which is a method of valuing Zura Bio by comparing valuation metrics of similar companies.Zura Bio is currently under evaluation in current valuation category among its peers.
Zura Fundamentals
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.21 | ||||
| Current Valuation | 105.46 M | ||||
| Shares Outstanding | 63.77 M | ||||
| Shares Owned By Insiders | 31.87 % | ||||
| Shares Owned By Institutions | 53.29 % | ||||
| Number Of Shares Shorted | 4.99 M | ||||
| Price To Book | 0.69 X | ||||
| EBITDA | (60.56 M) | ||||
| Net Income | (60.56 M) | ||||
| Total Debt | 21.29 M | ||||
| Book Value Per Share | 2.34 X | ||||
| Cash Flow From Operations | (15.05 M) | ||||
| Short Ratio | 5.43 X | ||||
| Earnings Per Share | 0.57 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.14 | ||||
| Market Capitalization | 295.78 M | ||||
| Total Asset | 100.84 M | ||||
| Retained Earnings | (103.49 M) | ||||
| Working Capital | 80.54 M | ||||
| Net Asset | 100.84 M |
About Zura Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zura Bio Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zura Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zura Bio Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:Check out Zura Bio Piotroski F Score and Zura Bio Altman Z Score analysis. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.